Novel Therapy May Be the First Line Treatment for Multiple Myeloma but Should Not Be the Last Word: Two Cases Illustrated
Lindsay McCullough, Amy C. Davis, Issam Hamadeh, Ashley Richards & Jan S. Moreb · International Journal of Medical and Pharmaceutical Case Reports · 2016
Over the past 20 years, the treatment for multiple myeloma (MM) has evolved significantly. These pharmaceutical developments allow physicians to combine existing chemotherapy with newly approved novel and targeted medications to create various treatment regimens for MM. These nov...
Open access
Research Article
10.9734/IJMPCR/2016/26538